INIA Biosciences develops non-invasive, home-administered, and closed-loop medical devices to manage chronic inflammatory diseases.
INIA Biosciences has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
INIA Biosciences's investors include MassChallenge, MedTech Innovator, BioInnovation Institute Venture Lab.
INIA Biosciences is headquartered in Boston, United States.
INIA Biosciences develops non-invasive, home-administered, and closed-loop medical devices to manage chronic inflammatory diseases.
INIA Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"INIA Biosciences — Funding & Investors." VCBacked, September 8, 2026, https://www.vcbacked.co/company/inia-biosciences. Accessed November 14, 2026.
VCBacked. (2026). INIA Biosciences — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/inia-biosciences
{{cite web |title=INIA Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/inia-biosciences |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at INIA Biosciences? Request a listing update